Traitomic A/S
A/SActiveAdvertising protectionCVR 43713523Gamle Carlsberg Vej 15, 1799 København VResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2022 · 3 years old30 employees
Loading company…
Overview
Traitomic A/S is a Danish A/S based in København V, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2022, the company has 30 employees and reported revenue of DKK 18.7m in its latest annual filing.
Revenue 2025
18.7M DKK
+4% vs 2024
EBITDA margin
−830.5 %
−373% vs 2024
Net profit 2025
-147.9M DKK
-450% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
34.7 %
WeakAmong the 40% lowest rated companies in the industry
20222025
Liquidity ratioCurrent assets ÷ Short-term debt
0.4×
Very weakAmong the 20% lowest rated companies in the industry
20222025
Return on assets (ROA)Net profit ÷ Total assets × 100
-137.8 %
Very weakAmong the 10% lowest rated companies in the industry
20222025
EBITDA — year on year
DKK millionsKey figures
Annual report 2025| Revenue | 18.7M DKK | +4% |
| EBITDA | -155.6M DKK | -373% |
| Net profit | -147.9M DKK | -450% |
| Total assets | 107.4M DKK | -54% |
| Equity | 37.2M DKK | -80% |
| Employees | 30 | — |
Company information
Legal name
TRAITOMIC A/S
CVR number
43713523
Legal form
Aktieselskab
Founded
16 December 2022 · 3 years
Share capital
DKK 1,000,239
Employees
30 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af ét medlem af bestyrelsen i forening med én direktør, eller af to
medlemmer af bestyrelsen i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive kommercielle aktiviteter inden for biotek, herunder udvikling af mikrober eller planter gennem en patenteret udviklingsteknologi samt enhver dertil knyttet aktivitet.
(no translation available)
Contact
Address
Gamle Carlsberg Vej 15, 1799 København V
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Traitomic A/S reported revenue of DKK 18.7m, an increase of 4% on the year before. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net loss of DKK 147.9m, and the EBITDA margin stood at -830.5%.
At the end of 2025, equity financed 34.7% of the balance sheet, and current assets covered short-term debt 0.4 times. Traitomic A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Financials
Revenue
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 18,736 | 18,027 | 23,202 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | -155,595 | -32,864 | -19,536 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -155,595 | -32,864 | -19,536 | 0 |
| Net financials | -2,932 | -1,912 | -6,669 | -368 |
| Profit before tax | -158,527 | -34,776 | -26,205 | -368 |
| Tax | -10,603 | -7,859 | -5,974 | -81 |
| Net profit | -147,924 | -26,917 | -20,231 | -287 |
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | 107,380 | 234,472 | 241,408 | 225,964 |
| Equity | 37,226 | 185,150 | 212,271 | 113 |
| Long-term debt | 31 | 0 | 0 | 0 |
| Short-term debt | 70,123 | 49,292 | 29,137 | 225,851 |
| Total debt | 70,154 | 49,292 | 29,137 | 225,851 |
Financial ratios
5-year trendEBITDA margin
-830.5 %
20222025
Equity ratio
34.7 %
WeakAmong the 40% lowest rated companies in the industry
20222025
Return on equity
-397.4 %
Very weakAmong the 10% lowest rated companies in the industry
20222025
Net profit margin
-789.5 %
Very weakAmong the 10% lowest rated companies in the industry
20222025
Asset turnover
0.17×
AverageAround the average of companies in the same industry
20222025
Debt / equity
1.88×
Very weakAmong the 20% lowest rated companies in the industry
20222025
Sector performance
28 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery weak
Among the 10% lowest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginVery weak
Among the 10% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginVery weak
Among the 10% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 10% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 10% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 10% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioVery weak
Among the 10% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery weak
Among the 20% lowest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 10% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery strong
Among the 20% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery weak
Among the 10% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioAverage
Around the average of companies in the same industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioWeak
Among the 40% lowest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioWeak
Among the 40% lowest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery weak
Among the 20% lowest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery weak
Among the 20% lowest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 10% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtVery weak
Among the 10% lowest rated companies in the industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtWeak
Among the 30% lowest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 10% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverAverage
Around the average of companies in the same industry
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Equity to contributed capitalVery strong
Among the 10% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 10% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtWeak
Among the 30% lowest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-12-16 – 2022-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GG Chief Executive Officer | Chief Executive Officer | 2022 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MI Chairman | Chairman | 2026 |
PS Board of Directors | Board of Directors | 2026 |
JA Board of Directors | Board of Directors | 2026 |
AR Board of Directors | Board of Directors | 2026 |
Former (5)
SB Chairman | Chairman | 2022 – 2025 |
CS Board of Directors | Board of Directors | 2025 – 2026 |
GZ Board of Directors | Board of Directors | 2025 – 2026 |
MK Board of Directors | Board of Directors | 2022 – 2025 |
HV Board of Directors | Board of Directors | 2022 – 2025 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2026 | |
| Individual | 25–33.32% | 25–33.32% | 2026 | |
| Company | 5–9.99% | 5–9.99% | 2026 | |
| Individual | 5–9.99% | 5–9.99% | 2026 | |
| Company | 5–9.99% | 5–9.99% | 2026 | |
| Company | 5–9.99% | 5–9.99% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Related companies
Company hierarchy
Carlsberg Breweries A/S
Traitomic A/S (this company)Board network connections
Board members of Traitomic A/S also hold positions in 9 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Ahm-Lundgren | Board of Directors | 5 companies |
| Søren Brinck | Chairman | 3 companies |
| Mads Krab | Board of Directors | 1 company |
Frequently asked questions
What is the CVR number of Traitomic A/S?
Traitomic A/S is registered with CVR / Virk under CVR 43713523.
What is the revenue of Traitomic A/S?
Traitomic A/S reported revenue of DKK 18.7m in 2025.
How many employees does Traitomic A/S have?
Traitomic A/S employs 30 people as of the latest annual report.
Who is the CEO of Traitomic A/S?
Gustav Göran Hambraeus is the CEO of Traitomic A/S.
Who is the chairman of Traitomic A/S?
Michaël Igor Krel chairs the board of Traitomic A/S, in role since 2026.
Where is Traitomic A/S headquartered?
Traitomic A/S's registered address is Gamle Carlsberg Vej 15.